Nano-X Imaging ended June 30, 2026, with $31.023 million in cash and expanded its U.S. and Latin American presence through distribution, Nanox.ARC and Nanox Imaging Network activity. The company intends to keep raising funds from various sources, a stated step to strengthen its Balance Sheet and support activities.
Key Highlights
- An additional Nanox.ARC capital-equipment agreement placed a system at a Florida orthopedic center within an integrated delivery network.
- The first Nanox Imaging Network site launched with first patient scans.
- Nanox.AI added Vertec Scientific as an exclusive reseller and launched five new pilot programs.
Nano-X Imaging Ltd. (NASDAQ: NNOX) reported an additional U.S. distribution agreement and a Costa Rica distribution agreement supporting continued expansion across Latin America while holding $31.023 million in cash at June 30, 2026. The balance stood at $49.151 million on December 31, 2025. The second-quarter Business update also covered Nanox.ARC sales, the first Nanox Imaging Network site and continued Nanox.AI commercial and clinical momentum.
Nanox.ARC Extends U.S. Reach
An additional U.S. distribution partner agreement expanded Nanox’s presence in the country. The company also added a Nanox.ARC capital-equipment agreement that placed a system at an internationally recognized orthopedic center in Florida, which is part of an integrated delivery network. The first Nanox Imaging Network site launched, with initial patient scans.
Nanox.AI Adds Commercial Momentum
The company also furthered a broad restructuring of its Korea operations, including its at-the-market program.
Balance Sheet and Funding
Nanox reported total Assets of $91.185 million at June 30, 2026, compared with $162.165 million at December 31, 2025. Total liabilities were $18.717 million at June 30, 2026, versus $22.433 million at December 31, 2025.
FAQs
Q: What did Nano-X Imaging report for the second quarter of 2026?
A: Nano-X Imaging reported expanded U.S. and Latin American activity, progress in Nanox.ARC sales, the first Nanox Imaging Network site and continued Nanox.AI commercial and clinical momentum.
Q: How does Nano-X Imaging plan to support its balance sheet?
A: The company said it intends to continue raising funds from various sources. It stated that these funds are intended to strengthen its balance sheet and support its activities.
Q: What was Nano-X Imaging’s cash balance at June 30, 2026?
A: Nano-X Imaging had $31.023 million in cash and cash equivalents at June 30, 2026. The balance was $49.151 million at December 31, 2025.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.